ADAR1 Capital Management »

Adicet Bio Ord shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 129k 8.42

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Adicet Bio Ord

Franklin Resources
Vanguard Group
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Acadian Asset Management
ADAR1 Capital Management
Geode Capital Management
Luminus Management
State Street Corporation
Barclays
GSA Capital Partners
FNY Investment Advisers
UBS Group

View all funds holding Adicet Bio Ord